(Q35824470)

10 August 2017

1 reference

title

Market Access Advancements and Challenges in "Drug-Companion Diagnostic Test" Co-Development in Europe (English)

1 reference

10 August 2017

Ildar Akhmetov

1

1 reference

10 August 2017

Rakshambikai Ramaswamy

series ordinal

2

1 reference

10 August 2017

Illias Akhmetov

series ordinal

3

1 reference

10 August 2017

Phani Kishore Thimmaraju

series ordinal

4

1 reference

10 August 2017

language of work or name

1 reference

12 June 2015

1 reference

Journal of personalized medicine

10 August 2017

1 reference

10 August 2017

5

1 reference

10 August 2017

2

1 reference

10 August 2017

213-228

1 reference

Creative Commons Attribution 4.0 International

10 August 2017

start time

12 June 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Personalized Medicine's Bottleneck: Diagnostic Test Evidence and Reimbursement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4493497

Aligning the economic value of companion diagnostics and stratified medicines

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4493497

Companion diagnostics for targeted cancer drugs - clinical and regulatory aspects

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4493497

Personalized medicine: part 2: ethical, legal, and regulatory issues

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4493497

Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4493497

Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4493497

The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4493497

Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4493497

The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4493497

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4493497

Do molecularly targeted agents in oncology have reduced attrition rates?

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26075972

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Biomarkers and receptor targeted therapies reduce clinical trial risk in non-small-cell lung cancer.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26075972

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Market access challenges in the EU for high medical value diagnostic tests

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26075972

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3390/JPM5020213

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

26075972

1 reference